دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
The Lancet Oncology
doi : 10.1016/S1470-2045(23)00465-5
Volume 24, Issue 10, October 2023, Page 1053
Combination immunotherapy in chemotherapy in gastric cancer
Kazuhiro Shiraishi, Shun Yamamoto, *Ken Kato
doi : 10.1016/S1470-2045(23)00404-7
Volume 24, Issue 10, October 2023, Pages 1054-1055
Combination therapy with olaparib and abiraterone acetate for metastatic castration-resistant prostate cancer
Alberto Martini, Giuseppe Fallara, Guillaume Ploussard, Bernard Malavaud
doi : 10.1016/S1470-2045(23)00448-5
Volume 24, Issue 10, October 2023, Pages 1056-1057
Hyperthermic intraperitoneal chemotherapy for ovarian cancer: long-term findings from the OVHIPEC-1 trial
Valentina Ghirardi, Anna Fagotti, *Giovanni Scambia
doi : 10.1016/S1470-2045(23)00447-3
Volume 24, Issue 10, October 2023, Pages 1057-1059
Cancer-predisposing germline variants and subsequent cancer risk
Cécile M Ronckers, Christian P Kratz, Amy Berrington de Gonzalez
doi : 10.1016/S1470-2045(23)00461-8
Volume 24, Issue 10, October 2023, Pages 1059-1061
Defining an evidence-based strategy for streamlining cancer multidisciplinary team meetings
*Tayana Soukup, Grant D Stewart, Benjamin W Lamb
doi : 10.1016/S1470-2045(23)00440-0
Volume 24, Issue 10, October 2023, Pages 1061-1063
Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer
Lachlan McDowell, Katherine A Hutcheson, Jolie Ringash
doi : 10.1016/S1470-2045(23)00387-X
Volume 24, Issue 10, October 2023, Page e396
Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer
Biswajyoti Das, Swarnaditya Roy, Anjali V Ramdulari, *Ahitagni Biswas
doi : 10.1016/S1470-2045(23)00445-X
Volume 24, Issue 10, October 2023, Page e397
Dysphagia-optimised intensity-modulated radiotherapy versus standard radiotherapy in patients with pharyngeal cancer – Authors' reply
Christopher Nutting, Laura Finneran, Justin Roe, Imran Petkar, Keith Rooney, Emma Hall
doi : 10.1016/S1470-2045(23)00457-6
Volume 24, Issue 10, October 2023, Page e398
Pembrolizumab monotherapy for advanced chordoma
Xianglin Hu, Chunmeng Wang, Wending Huang, Sean M Barber, *Wangjun Yan
doi : 10.1016/S1470-2045(23)00395-9
Volume 24, Issue 10, October 2023, Page e399
Pembrolizumab monotherapy for advanced chordoma – Authors' reply
Jean-Yves Blay, Nicolas Penel, Florence Duffaud, Emmanuelle Bompas, Christophe Massard, Sylvie Chevret
doi : 10.1016/S1470-2045(23)00454-0
Volume 24, Issue 10, October 2023, Page e400
Combination therapies in non-clear-cell renal cell carcinoma
*Volkan Aslan, Nuriye ?zdemir, Ozan Yaz?c?, Ahmet ?zet
doi : 10.1016/S1470-2045(23)00393-5
Volume 24, Issue 10, October 2023, Page e401
Common Sense Oncology: including everyone
Nicolas Andr
doi : 10.1016/S1470-2045(23)00413-8
Volume 24, Issue 10, October 2023, Page e402
Common Sense Oncology: including everyone
Yakup Ergun
doi : 10.1016/S1470-2045(23)00359-5
Volume 24, Issue 10, October 2023, Page e403
Common Sense Oncology: including everyone – Authors' reply
Christopher M Booth, Manju Sengar, Aaron Goodman, Brooke Wilson, Bishal Gyawali
doi : 10.1016/S1470-2045(23)00464-3
Volume 24, Issue 10, October 2023, Page e404
Correction to Lancet Oncol 2023; 24: 892–902
doi : 10.1016/S1470-2045(23)00458-8
Volume 24, Issue 10, October 2023, Page e405
Correction to Lancet Oncol 2023; 24: 989–1001
doi : 10.1016/S1470-2045(23)00463-1
Volume 24, Issue 10, October 2023, Page e405
Correction to Lancet Oncol 2023; 24: 1042–52
doi : 10.1016/S1470-2045(23)00439-4
Volume 24, Issue 10, October 2023, Page e405
Cancer care after the wildfires in Hawai'i
Manjulika Das
doi : 10.1016/S1470-2045(23)00437-0
Volume 24, Issue 10, October 2023, Page 1064
Africa reaffirms commitments to eliminate cervical cancer
Munyaradzi Makoni
doi : 10.1016/S1470-2045(23)00450-3
Volume 24, Issue 10, October 2023, Page 1065
Cancer advocates call for national cancer body in South Africa
Munyaradzi Makoni
doi : 10.1016/S1470-2045(22)00789-6
Volume 24, Issue 10, October 2023, Page 1066
The UK rejoins Horizon Europe
Talha Khan Burki
doi : 10.1016/S1470-2045(22)00790-2
Volume 24, Issue 10, October 2023, Page 1067
US Government convenes first National Cancer Plan stakeholders' meeting
Bryant Furlow
doi : 10.1016/S1470-2045(23)00107-9
Volume 24, Issue 10, October 2023, Page 1068
Cancer care in Sri Lanka amid financial crisis
Manjulika Das
doi : 10.1016/S1470-2045(23)00472-2
Volume 24, Issue 10, October 2023, Page e406
Developing cancer rehabilitation services and research in low-income and middle-income countries: the case for Zambia and key messages
Mulenga Davie, Lishimpi Kennedy, Kangwa Chilimboyi, Meda Chikonge, Aaron Lunda Shibemba, Julie Phillips, Juliette Hussey
doi : 10.1016/S1470-2045(23)00441-2
Volume 24, Issue 10, October 2023, Pages 1069-1071
The deaf doctor
Simon Wein
doi : 10.1016/S1470-2045(23)00442-4
Volume 24, Issue 10, October 2023, Page 1072
First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: a single-arm, single-centre, phase 2 trial
Samuel L Cytryn, Ryan H Moy, Darren Cowzer, Ronak H Shah, Joanne F Chou, Smita S Joshi, Geoffrey Y Ku, Steven B Maron, Avni Desai, Jessica Yang, Ryan Sugarman, Devika Rao, Zoe Goldberg, Carmelina Charalambous, Maria Lapshina, Ariel Antoine, Fiona Socolow, Nikhil Trivedi, Marinela Capanu, Hans Gerdes, Mark A Schattner, Marc Simmons, Mario E Lacouture, Viktoriya Paroder, Laura H Tang, Jinru Shia, David H Ilson, David B Solit, Michael F Berger, Yelena Y Janjigian
doi : 10.1016/S1470-2045(23)00358-3
Volume 24, Issue 10, October 2023, Pages 1073-1082
Conventional versus hypofractionated postmastectomy proton radiotherapy in the USA (MC1631): a randomised phase 2 trial
Robert W Mutter, Sharmila Giri, Briant F Fruth, Nicholas B Remmes, Judy C Boughey, Christin A Harless, Kathryn J Ruddy, Lisa A McGee, Arslan Afzal, Robert W Gao, Dean A Shumway, Tamara Z Vern-Gross, Hector R Villarraga, Stephanie L Kenison, Yixiu Kang, William W Wong, Bradley J Stish, Kenneth W Merrell, Elizabeth S Yan, Sean S Park, Kimberly S Corbin, Carlos E Vargas
doi : 10.1016/S1470-2045(23)00388-1
Volume 24, Issue 10, October 2023, Pages 1083-1093
Olaparib plus abiraterone versus placebo plus abiraterone in metastatic castration-resistant prostate cancer (PROpel): final prespecified overall survival results of a randomised, double-blind, phase 3 trial
Fred Saad, Noel W Clarke, Mototsugu Oya, Neal Shore , Giuseppe Procopio, Jo?o Daniel Guedes, Cagatay Arslan, Niven Mehra, Francis Parnis, Emma Brown, Friederike Schlürmann, Jae Young Joung, Mikio Sugimoto, Oliver Sartor, Yu-Zhen Liu, Christian Poehlein, Laura Barker, Paula Michelle del Rosario, Andrew J Armstrong
doi : 10.1016/S1470-2045(23)00382-0
Volume 24, Issue 10, October 2023, Pages 1094-1108
Cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy in patients with advanced ovarian cancer (OVHIPEC-1): final survival analysis of a randomised, controlled, phase 3 trial
S Lot Aronson, Marta Lopez-Yurda, Simone N Koole, Jules H Schagen van Leeuwen, Hendrik W R Schreuder, Ralph H M Hermans, Ignace H J T de Hingh, Mignon D J M van Gent, Henriëtte J G Arts, Maaike A P C van Ham, Peter A van Dam, Peter Vuylsteke, Arend G J Aalbers, Victor J Verwaal, Koen K Van de Vijver, Neil K Aaronson, Gabe S Sonke*, Willemien J van Driel*
doi : 10.1016/S1470-2045(23)00396-0
Volume 24, Issue 10, October 2023, Pages 1109-1118
Treatment of primary plasma cell leukaemia with carfilzomib and lenalidomide-based therapy (EMN12/HOVON-129): final analysis of a non-randomised, multicentre, phase 2 study
Niels W C J van de Donk, Monique C Minnema, Bronno van der Holt, Fredrik Schjesvold, Ka Lung Wu, Annemiek Broijl, Wilfried W H Roeloffzen, Alain Gadisseur, Giuseppe Pietrantuono, Ludek Pour, Vincent H J van der Velden, Thomas Lund, Massimo Offidani, Mariella Grasso, Luisa Giaccone, Wida Razawy, Paola Tacchetti, Katia Mancuso, Trine Silkjaer, Jo Caers, Sonja Zweegman, Roman H?jek, Reuben Benjamin, Annette Juul Vangsted, Mario Boccadoro, Francesca Gay, Pieter Sonneveld, Pellegrino Musto
doi : 10.1016/S1470-2045(23)00405-9
Volume 24, Issue 10, October 2023, Pages 1119-1133
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
Xiangyu Gao*, Nong Xu*, Ziyu Li*, Lin Shen*, Ke Ji*, Zhong Zheng*, Dan Liu, Hanmei Lou, Li Bai, Tianshu Liu, Yunxia Li, Yuzhi Li, Qingxia Fan, Mei Feng, Haijun Zhong, Yi Huang, Ge Lou, Jing Wang, Xiaoyan Lin, Ye Chen, Ruifang An, Changzheng Li, Qi Zhou, Xin Huang, Zengqing Guo, Shubin Wang, Guiling Li, Junwei Fei, Lijing Zhu, Hong Zhu, Xiumin Li, Fenghu Li, Sihai Liao, Qinghua Min, Lei Tang, Fei Shan, Jifang Gong, Yunong Gao, Jun Zhou, Zhihao Lu, Xiaofan Li, Jianjie Li, Hui Ren, Xiaohong Liu, Hongxia Yang, Wenting Li, Weifeng Song, Zhongmin Maxwell Wang, Baiyong Li, Michelle Xia, Xiaohua Wu, Jiafu Ji
doi : 10.1016/S1470-2045(23)00411-4
Volume 24, Issue 10, October 2023, Pages 1134-1146
Cancer germline predisposing variants and late mortality from subsequent malignant neoplasms among long-term childhood cancer survivors: a report from the St Jude Lifetime Cohort and the Childhood Cancer Survivor Study
Cheng Chen*, Na Qin*, Mingjuan Wang*, Qian Dong, Saima Sultana Tithi, Yawei Hui, Wenan Chen, Gang Wu, Dennis Kennetz, Michael N Edmonson, Michael C Rusch, Andrew Thrasher, John Easton, Heather L Mulder, Nan Song, Noel-Marie Plonski, Kyla Shelton, Cindy Im, Matthew J Ehrhardt, Kim E Nichols, Wendy M Leisenring, Kayla L Stratton, Rebecca Howell, Yutaka Yasui, Smita Bhatia, Gregory T Armstrong, Kirsten K Ness, Melissa M Hudson, Jinghui Zhang, Hui Wang†, Deo Kumar Srivastava†, Leslie L Robison†, Zhaoming Wang
doi : 10.1016/S1470-2045(23)00403-5
Volume 24, Issue 10, October 2023, Pages 1147-1156
Global oncology research and training at US National Cancer Institute-designated cancer centres: results of the 2021 Global Oncology Survey
Elise M Garton, Mishka K Cira, Patrick J Loehrer, Linsey Eldridge, Allison Frank, Laura Prakash, Shine Chang, Ramzi G Salloum, Henry Ciolino, Min He, Satish Gopal, Kalina Duncan
doi : 10.1016/S1470-2045(23)00385-6
Volume 24, Issue 10, October 2023, Pages e407-e414
Measuring ovarian toxicity in clinical trials: an American Society of Clinical Oncology research statement
Wanda Cui, Rodney P Rocconi, Ramya Thota, Richard A Anderson, Suanna S Bruinooge, Ioanna A Comstock, Neelima Denduluri, Audrey Gassman, Julie Gralow, Karla J Hutt, Laleh Amiri-Kordestani, Matteo Lambertini, John Leighton, Karen H Lu, Sogol Mostoufi-Moab, Teri Pollastro, Shan Pradhan, Haleh Saber, Caroline Schenkel, Daniel Spratt, Suparna Wedam, Kelly-Anne Phillips
doi : 10.1016/S1470-2045(23)00390-X
Volume 24, Issue 10, October 2023, Pages e415-e423
Amelanotic melanoma presented as multiple flesh-coloured islands
Tai-Li Chen, Chih-Chiang Chen
doi : 10.1016/S1470-2045(23)00355-8
Volume 24, Issue 10, October 2023, Page e424
